You are here

Drug Forecast

Novel Treatment of Allergic Asthma and Seasonal Allergic Rhinitis: Focus on Omalizumab (Xolair®)

Boris Nogid, PharmD, and Timothy S. McCall, RPh
PDF version: 
Omalizumab is being touted as a new treatment for patients with allergic disorders.